Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis Article

cited authors

  • Hennan, J. K.; Morgan, G. A.; Swillo, R. E.; Antrilli, T. M.; Mugford, C.; Vlasuk, G. P.; Gardell, S. J.; Crandall, D. L.

authors

Publication Date

  • September 1, 2008

webpage

published in

category

keywords

  • PAI-1
  • fibrinolysis
  • thrombosis
  • vascular injury

start page

  • 1558

end page

  • 1564

volume

  • 6

issue

  • 9